Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test
Authors:
- Attila PálinkásAPAttila Pálinkás
- Emanuele NicolaiENEmanuele Nicolai
- Francesco Saverio MarescaFMFrancesco Saverio Maresca
- Albert VargaAVAlbert Varga
- Eugenio PicanoEPEugenio Picano
- 1 March 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 19 (3) , 495-502
Abstract
Many different stress echocardiographic and radionuclide perfusion imaging tests have been proposed for detecting epicardial coronary artery disease (CAD) in hypertensive patients. Their relative diagnostic and prognostic value has not been exactly established. A positive exercise electrocardiography test has a low diagnostic specificity in hypertensive patients and warrants for a complementary imaging test to confirm the diagnosis of coronary artery disease. Hypertensive patients (n = 53), (29 males, aged 58 ± 10 years) with normal left ventricular function detected by echocardiography and previous positive exercise test (≥ 0.15 mV of ST segment depression on 12 lead electrocardiogram) underwent dipyridamole-atropine stress echocardiography (DASE) and thallium-201 stress/rest myocardial single-photon emission computed tomography (SPECT). All patients had coronary angiography within 15 days and independently of imaging test results. Coronary angiogram showed significant (≥ 50% qualitatively assessed diameter reduction) epicardial coronary artery disease in 23 (43%) patients. Sensitivity for detection of coronary artery disease was significantly higher for scintigraphy (DASE = 78% versus SPECT = 100%, P 0.05) while specificity was higher for echo (DASE = 100% versus SPECT = 47%, P 0.00001). Diagnostic accuracy was also higher for echo (DASE = 91% versus SPECT = 70%, P 0.01).ConclusionIn patients with exercise-nduced ST segment depression, dipyridamole stress echo and SPECT perfusion scintigraphy are both good diagnostic options, with DASE characterized by higher specificity, lower sensitivity, and at least comparable diagnostic accuracy than SPECT. In patients with exercise-nduced ST segment depression, dipyridamole stress echo and SPECT perfusion scintigraphy are both good diagnostic options, with DASE characterized by higher specificity, lower sensitivity, and at least comparable diagnostic accuracy than SPECT.Keywords
This publication has 32 references indexed in Scilit:
- Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Assessment of the Coronary Artery Disease and Systolic Dysfunction in Hypertensive Patients with the Dobutamine-Atropine Stress Echocardiography: Effect of the Left Ventricular HypertrophyCardiology, 1997
- Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive PatientsHypertension, 1997
- ACC/AHA Guidelines for the Clinical Application of Echocardiography: Executive SummaryJACC, 1997
- Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patientsEuropean Heart Journal, 1996
- Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise Thallium-201 scintigraphyThe American Journal of Cardiology, 1995
- ST segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patients.Hypertension, 1990
- Dipyridamole echocardiography in essential hypertensive patients with chest pain.Hypertension, 1988
- How can we diagnose coronary heart disease in hypertensive patients?Hypertension, 1987
- Thallium-201 stress imaging in hypertensive patients.Hypertension, 1987